Trial
NCT02599961
Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Ultragenyx Pharmaceutical Inc
Collaborators
—
Condition
Glucose Transporter Type 1 Deficiency Syndrome
Intervention
UX007
Why stopped
Study was halted prematurely due to lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-11